Amanote Research

Amanote Research

  • Register
  • Sign In

Diagnostics in Cancer Drug Development

Expert Review of Molecular Diagnostics- United Kingdom

doi 10.1586/14737159.4.2.127

Full Text

Abstract

Available in

Categories

Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology

Date

March 1, 2004

Authors

Karol Sikora

Publisher

Informa UK Limited


Related search

Molecular Imaging in Cancer Drug Development

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018Dutch

Machine Learning in Cancer Diagnostics

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Regulatory Considerations on Endpoints in Ovarian Cancer Drug Development

Cancer
Cancer ResearchOncology
2017English

Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics Up to the Standards for Drug Development

Clinical Cancer Research
Cancer ResearchOncology
2012English

Drug Development and Registration: Challenges and Opportunities in Ovarian Cancer

Cancer
Cancer ResearchOncology
2017English

AKT in Cancer: New Molecular Insights and Advances in Drug Development

British Journal of Clinical Pharmacology
Pharmacology
2016English

Opportunities and Challenges of Implementing Pharmacogenomics in Cancer Drug Development

2019English

An in Vivo Platform for Translational Drug Development in Pancreatic Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

Array-Based “Chemical Nose” Sensing in Diagnostics and Drug Discovery

Angewandte Chemie - International Edition
CatalysisChemistry
2019English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy